Search Page

1

Cite

Share

Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience.

Silva C, Moon JC, Elkington AG, John AS, Mohiaddin RH, Pennell DJ. Silva C, et al. Among authors: elkington ag. J Cardiovasc Med (Hagerstown). 2007 Dec;8(12):1076-9. doi: 10.2459/01.JCM.0000296538.82763.f0. J Cardiovasc Med (Hagerstown). 2007. PMID: 18163027

Cite

Share

2

Cite

Share

Segmentation of 4D cardiac MR images using a probabilistic atlas and the EM algorithm.

Lorenzo-Valdés M, Sanchez-Ortiz GI, Elkington AG, Mohiaddin RH, Rueckert D. Lorenzo-Valdés M, et al. Among authors: elkington ag. Med Image Anal. 2004 Sep;8(3):255-65. doi: 10.1016/j.media.2004.06.005. Med Image Anal. 2004. PMID: 15450220

Cite

Share

3

Cite

Share

Optimization of the arterial input function for myocardial perfusion cardiovascular magnetic resonance.

Elkington AG, He T, Gatehouse PD, Prasad SK, Firmin DN, Pennell DJ. Elkington AG, et al. J Magn Reson Imaging. 2005 Apr;21(4):354-9. doi: 10.1002/jmri.20294. J Magn Reson Imaging. 2005. PMID: 15779035

Cite

Share

4

Cite

Share

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.

Moon JC, Mogensen J, Elliott PM, Smith GC, Elkington AG, Prasad SK, Pennell DJ, McKenna WJ. Moon JC, et al. Among authors: elkington ag. Heart. 2005 Aug;91(8):1036-40. doi: 10.1136/hrt.2004.041384. Heart. 2005. PMID: 16020591 Free PMC article.

Cite

Share

5

Cite

Share

The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study.

Moon JC, De Arenaza DP, Elkington AG, Taneja AK, John AS, Wang D, Janardhanan R, Senior R, Lahiri A, Poole-Wilson PA, Pennell DJ. Moon JC, et al. Among authors: elkington ag. J Am Coll Cardiol. 2004 Aug 4;44(3):554-60. doi: 10.1016/j.jacc.2004.03.076. J Am Coll Cardiol. 2004. PMID: 15358019 Free article.

Cite

Share

6

Cite

Share

Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease.

Webb CM, Elkington AG, Kraidly MM, Keenan N, Pennell DJ, Collins P. Webb CM, et al. Among authors: elkington ag. Am J Cardiol. 2008 Mar 1;101(5):618-24. doi: 10.1016/j.amjcard.2007.09.114. Epub 2007 Dec 21. Am J Cardiol. 2008. PMID: 18308009 Free PMC article. Clinical Trial.

Cite

Share

7

Cite

Share

Accurate assessment of the arterial input function during high-dose myocardial perfusion cardiovascular magnetic resonance.

Gatehouse PD, Elkington AG, Ablitt NA, Yang GZ, Pennell DJ, Firmin DN. Gatehouse PD, et al. Among authors: elkington ag. J Magn Reson Imaging. 2004 Jul;20(1):39-45. doi: 10.1002/jmri.20054. J Magn Reson Imaging. 2004. PMID: 15221807

Cite

Share

8

Cite

Share

Interstudy reproducibility of quantitative perfusion cardiovascular magnetic resonance.

Elkington AG, Gatehouse PD, Ablitt NA, Yang GZ, Firmin DN, Pennell DJ. Elkington AG, et al. J Cardiovasc Magn Reson. 2005;7(5):815-22. doi: 10.1080/10976640500287877. J Cardiovasc Magn Reson. 2005. PMID: 16353442

Cite

Share

9

Cite

Share

Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

Moon JC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ, Leed PJ, Elliott PM. Moon JC, et al. Among authors: elkington ag. Eur Heart J. 2003 Dec;24(23):2151-5. doi: 10.1016/j.ehj.2003.09.017. Eur Heart J. 2003. PMID: 14643276 Clinical Trial.

Cite

Share

10

Cite

Share

The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ. Moon JC, et al. Among authors: elkington ag. J Am Coll Cardiol. 2004 Jun 16;43(12):2260-4. doi: 10.1016/j.jacc.2004.03.035. J Am Coll Cardiol. 2004. PMID: 15193690 Free article.

Cite

Share